Calan Sr
Calan Sr
- In our pharmacy, you can buy calan sr without a prescription, with delivery across Canada and discreet packaging.
- Calan SR (verapamil) is used to treat hypertension, angina pectoris and certain supraventricular arrhythmias; it is a phenylalkylamine calcium‑channel blocker that inhibits L‑type calcium channels in cardiac and vascular smooth muscle, reducing myocardial contractility, AV‑nodal conduction and causing vasodilation.
- Usual dosage: Hypertension typically 180–240 mg/day (ER once daily or divided); angina often 80–120 mg three times daily (immediate‑release); arrhythmias commonly 240–320 mg/day in divided doses. Lower starting doses are recommended in the elderly and in hepatic impairment.
- Form of administration: oral tablets/capsules — immediate‑release (40, 80, 120 mg) and extended‑release/sustained‑release tablets or capsules (120, 180, 240 mg). Do not crush or chew extended‑release forms.
- Onset time: immediate‑release formulations begin working within about 30–60 minutes; extended‑release/sustained‑release formulations generally start to take effect within 1–2 hours with a more gradual onset.
- Duration of action: immediate‑release effects last roughly 4–6 hours; extended‑release formulations provide effect for approximately 12–24 hours, permitting once‑daily dosing for many patients.
- Alcohol warning: avoid or limit alcohol — it can increase dizziness and hypotension and worsen side effects such as drowsiness and lightheadedness.
- The most common side effect is constipation; other common effects include dizziness, headache, fatigue, peripheral oedema and bradycardia.
- Would you like to try calan sr without a prescription?
Availability & Price Landscape
Basic Calan Sr Information
- INN (International Nonproprietary Name): Verapamil
- Brand Names Available In Canada (English): Calan, Calan SR (USA); Isoptin, Isoptin SR (Europe, Canada); Verelan, Verelan PM (USA); Covera-HS (USA); Tarka (USA/Canada); Vérapamil / Verapamilo / Verapamilum (various regions)
- ATC Code: C08DA01 — Cardiovascular system; Calcium channel blockers; Phenylalkylamine derivatives; Verapamil
- Forms & Dosages: Immediate-release tablet 40 mg, 80 mg, 120 mg; Extended-release tablet 120 mg, 180 mg, 240 mg; Extended-release capsule 120 mg, 180 mg, 240 mg
- Manufacturers In Canada (English): Pfizer (Calan SR, US); Abbott Laboratories; Knoll; Mylan; Sandoz; numerous generics
- Registration Status In Canada (English): Approved widely by national regulators for hypertension, angina, and arrhythmias; specific Canadian DINs should be checked per SKU
- OTC / Rx Classification: Prescription-only (Rx) medicine in major markets
- Approved Indications And Dosage Recommendations: Hypertension 180–240 mg/day (divided doses or ER once daily); Angina 80–120 mg three times daily (IR); Arrhythmias 240–320 mg/day divided
- Storage And Transport: Store at room temperature 15–30°C, away from moisture and heat; keep out of reach of children
- Contraindications: Severe hypotension, advanced AV block without pacemaker, sick sinus syndrome without pacemaker, known hypersensitivity, severe heart failure
Which pharmacies actually stock verapamil SR in Canada and what will it cost?
Major national chains such as Shoppers Drug Mart and Rexall commonly carry extended-release verapamil products or can order them, with Isoptin SR and multiple generics most often seen on shelves.
Jean Coutu tends to be the most visible supplier in Quebec, while London Drugs is a common source in Western provinces for both immediate- and extended-release verapamil.
Calan SR is a Pfizer-labelled product mainly cited in U.S. materials, and Canadian retail listings more often show Isoptin or simply “verapamil extended release.”
All verapamil products are prescription-only under Health Canada, and availability varies by chain and province.
Online pharmacy growth is notable, but provincial dispensing rules can limit out-of-province shipment for some public plans.
Many patients price-shop between local stores, online Canadian pharmacies, and U.S. websites, checking formulation equivalence (ER vs IR) before ordering.
Typical price bands (estimated): generic verapamil SR 120–240 mg — low-to-mid CAD per 30-tablet pack; branded SR formulations are commonly higher.
Provincial drug plan coverage differs widely: Ontario Drug Benefit, BC PharmaCare, and RAMQ have variable listing and prior-authorisation rules that affect patient cost.
Cross-Border Tips:
- Confirm the formulation (extended release vs immediate release) before comparing prices.
- Check DIN correspondence and pharmacist oversight to ensure equivalence.
- Factor in shipping times and winter shipping protections for Canadian climates.
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms
Where are Canadians talking about verapamil SR?
Discussions appear across Reddit Canada, HealthBoards, and AskDocs threads, often in hypertension and cardiology subforums or provincial health groups.
Province-specific threads mention local pharmacy experiences, with Quebec posts naming Jean Coutu and BC posts praising London Drugs pharmacist consultations.
Reported Benefits And Challenges From Canadian Patients
Many patients report effective blood pressure and angina control after switching to extended-release verapamil, especially at once-daily ER doses between 180–240 mg for hypertension.
Extended-release formulations are credited with steady symptom relief and improved adherence compared with immediate-release three-times-daily regimens.
Commonly reported challenges include constipation as the most frequent side effect, plus fatigue, dizziness, ankle oedema, and occasional bradycardia when combined with beta-blockers.
Some elderly patients describe slow titration schedules with close monitoring of BP and heart rate.
Price-driven anecdotes about cross-border purchases surface regularly; many users stress the importance of confirming ER formulation and DIN equivalence.
Pros And Cons (Patient Sentiment):
- Pros: Once-daily ER dosing, good rate control for arrhythmias, reliable angina relief.
- Cons: Constipation most common; interactions with beta-blockers; need for careful titration in elderly or hepatic impairment.
Sample anonymised forum quotes:
“Switched to Isoptin SR 180 mg once daily and my BP is steadier — no more midday dips.”
“Watch the constipation — ask your pharmacist for management tips.”
Product Overview & Brand Variants
INN And Brand Names Used In Canada
What will the label say?
The International Nonproprietary Name is verapamil, and Canadian patients will most often see Isoptin, Isoptin SR, or generic verapamil extended-release products on pharmacy shelves.
Calan and Calan SR are Pfizer-branded terms cited widely in U.S. materials, but Canadian retail commonly lists Isoptin or the generic INN.
Legal Classification Under Health Canada
All verapamil products are prescription-only medicines; each marketed SKU is assigned a Drug Identification Number (DIN) that links to its product monograph and approved indications.
Available dosage forms include immediate-release tablets in 40 mg, 80 mg, and 120 mg, and extended-release tablets or capsules in 120 mg, 180 mg, and 240 mg.
Typical Canadian suppliers and generics include Mylan and Sandoz among others.
| SKU | Brand | Form | DIN (Placeholder) |
|---|---|---|---|
| Example-1 | Isoptin SR | ER Tablet 180 mg | Not Specified |
| Example-2 | Generic Verapamil | ER Tablet 240 mg | Not Specified |
Definition Highlights:
- INN: International Nonproprietary Name — verapamil.
- Brand: Manufacturer trade name such as Isoptin or Calan.
- ER vs IR: Extended-release avoids multiple daily dosing; immediate-release is typically three-times-daily for angina.
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada DIN Context)
Which conditions is verapamil used for in Canada?
Approved indications commonly listed in product monographs and regulatory documents include hypertension, chronic stable angina, and certain supraventricular arrhythmias such as SVT.
Typical adult dosing ranges used in Canadian practice are consistent with monograph guidance: hypertension often 180–240 mg/day (ER once daily or divided); angina with immediate-release 80–120 mg three times daily; arrhythmia regimens up to 240–320 mg/day divided.
Off-Label Patterns In Canadian Healthcare
Off-label uses are limited and specialist-driven, such as rare paediatric arrhythmia management under cardiology care.
Caution is advised for rate control in atrial fibrillation where alternatives may be preferred depending on comorbidities.
Provincial formulary listings can affect which formulation is first-line on a given formulary, and some uses require prior authorisation.
| Indication | Typical Canadian Regimen / Notes |
|---|---|
| Hypertension | 180–240 mg/day (ER once daily or divided); monitor BP |
| Chronic Stable Angina | Immediate-release 80–120 mg three times daily; ER options for maintenance |
| Supraventricular Arrhythmias (SVT) | 240–320 mg/day divided; specialist input recommended |
How It Works In The Body
Layman’s Explanation
What does verapamil do and why will it help my condition?
Verapamil belongs to the phenylalkylamine class of calcium channel blockers and reduces calcium entry into heart and vessel cells.
That action relaxes arteries to lower blood pressure, slows conduction through the AV node to help control heart rate in some arrhythmias, and reduces myocardial oxygen demand to relieve angina.
Clinical Detail From Health Canada Resources
Verapamil’s negative inotropic (reduces contractility) and negative chronotropic (reduces heart rate) effects explain why it is used cautiously in heart failure and combined carefully with beta-blockers.
What To Expect:
- Lowered blood pressure and fewer angina episodes with regular dosing.
- Slower heart rate and improved control of certain supraventricular arrhythmias.
- Potential side effects such as constipation and dizziness linked to the same mechanism.
Clinical Bullet List:
- ATC: C08DA01 phenylalkylamine calcium channel blocker.
- Reduces AV nodal conduction — useful for SVT and rate control in selected patients.
- Use caution in heart failure due to negative inotropic effects.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
How is verapamil typically dosed?
Hypertension: commonly 180–240 mg/day given as an ER tablet once daily or in divided doses depending on formulation and tolerability.
Angina: immediate-release dosing is often 80–120 mg three times daily for symptom control.
Arrhythmias: regimens range from 240–320 mg/day divided, with cardiology oversight for higher doses.
Adjustments By Patient Type (With Canadian Clinical Notes)
Administration notes: swallow extended-release tablets whole; do not crush or chew ER formulations.
Start lower in elderly patients and those with hepatic impairment due to increased sensitivity and slower clearance.
When combining with beta-blockers, monitor blood pressure and heart rate closely to avoid bradycardia or heart block.
Missed dose advice: take when remembered unless it is almost time for the next dose; do not double doses.
Practical Titration Steps:
- Begin with the lowest recommended ER dose for hypertension in older adults.
- Wait 1–2 weeks and reassess BP and HR before increasing dose.
- Adjust slowly, especially when adding other rate-lowering agents.
Contraindications & Side Effects
Common (Health Canada-Approved List)
Who should not take verapamil?
Absolute contraindications include severe hypotension (systolic <90 mmHg), second- or third-degree AV block without a pacemaker, sick sinus syndrome without a pacemaker, known hypersensitivity to verapamil, and severe heart failure.
Common side effects include constipation (the most frequent), dizziness, headache, fatigue, peripheral oedema, nausea, and bradycardia.
Rare But Serious (With Canadian Pharmacovigilance Data)
Rare but serious events include profound hypotension, severe bradyarrhythmia requiring intervention, and drug interactions precipitating heart block when combined with beta-blockers or other negative chronotropes.
When To Seek Help:
- Severe dizziness or fainting.
- Very slow pulse or loss of consciousness.
- Signs of severe low blood pressure or overdose.
Common Interaction-Prone Drug Classes:
| Drug Class | Interaction Concern |
|---|---|
| Beta-Blockers | Risk of bradycardia and AV block; monitor closely |
| CYP3A4 Substrates (certain statins) | Potential increased levels — check specific statin guidance |
Comparable Medicines In Canada
Alternatives Table (With DIN References)
| Drug | Class | Typical Use | Pros / Cons | DIN (Placeholder) |
|---|---|---|---|---|
| Diltiazem (Cardizem / Tiazac) | Calcium Channel Blocker (non-phenylalkylamine) | Hypertension, angina, rate control | Less constipation than verapamil; moderate AV node effect | Not Specified |
| Amlodipine (Norvasc) | Dihydropyridine CCB | Hypertension, angina | Potent vasodilation; less effect on heart rate; more peripheral oedema | Not Specified |
| Atenolol / Metoprolol | Beta-Blockers | Hypertension, rate control | Good rate control; avoid in some reactive airway disease | Not Specified |
Pros And Cons List
- Verapamil: Strong AV node effect — helpful for arrhythmias; con is constipation and bradycardia risk.
- Amlodipine: Excellent BP control and tolerability for many patients; con is peripheral oedema and minimal AV effect.
- Diltiazem: Middle ground for BP and rate control; fewer GI side effects than verapamil.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
What recent evidence affects verapamil use?
Recent literature continues to emphasise that dihydropyridine CCBs are often favoured for primary hypertension because of tolerability, while verapamil remains important for rhythm-specific indications such as SVT.
Studies from 2022–2025 have focused on personalised dosing strategies for elderly patients to reduce bradycardia and hypotension risk with ER formulations.
Pharmacokinetic data for ER products have clarified consistent once-daily exposure advantages versus IR forms and informed switching protocols.
Practical implications include careful patient selection for verapamil when arrhythmia control is required and favouring dihydropyridine agents for isolated hypertension in many cases.
Guideline Links To Watch: local bodies such as the Canadian Cardiovascular Society and provincial cardiac care programs publish updates that influence formulary and prescribing choices.
Common Patient Questions In Canada
Practical Q&A (Dosage, Interactions, Driving, Pregnancy)
Do I need a prescription?
Yes, verapamil products are prescription-only and are dispensed by DIN-linked SKUs; check with a prescriber or pharmacist if uncertain.
Can I crush my tablet?
No — do not crush or chew extended-release tablets as this destroys the ER mechanism and may cause overdose.
Will verapamil affect driving?
Possibly — dizziness and fatigue are common early side effects, so avoid driving until you know how it affects you.
What about pregnancy or breastfeeding?
Verapamil is generally not recommended in pregnancy or nursing unless clearly needed; specialist advice is advised.
When To Contact Pharmacist Or Doctor
Contact the pharmacist or prescriber for severe dizziness, fainting, very slow pulse, or any signs of severe allergic reaction.
Seek emergency care for suspected overdose, severe hypotension, or altered consciousness.
Coverage question: provincial drug plans (ODB, BC PharmaCare, RAMQ) differ — check with the pharmacy for eligibility and prior-authorisation requirements.
Regulatory Status
Health Canada Approval Process
How is verapamil regulated in Canada?
Health Canada requires submission of clinical and quality data for approval; each authorised product receives a Drug Identification Number (DIN) that links to its product monograph and approved indications.
Pharmacies should display the exact DIN and monograph link per SKU, and verify provincial formulary listing or prior-authorisation rules before dispensing for public plans.
DIN Number Relevance
The DIN is the identifier that ties a marketed product to its approved label and safety information; maintaining an up-to-date DIN database helps avoid dispensing errors and ensures correct counselling.
Definition List:
- DIN: Drug Identification Number — product-specific code used in Canada.
- NOC: Notice of Compliance — regulatory approval term.
- Monograph: The official product information detailing indications, dosing, contraindications, and pharmacology.
Visual Recommendations
Infographic Ideas For Canadian Context
Suggested visuals for a product page include a dosing infographic comparing IR vs ER regimens and a provincial coverage map highlighting ODB, BC PharmaCare, and RAMQ differences.
Create a contraindications checklist graphic using red/amber/green cues and an interactions chart for beta-blockers and CYP3A4 substrates.
Images And Accessible Assets For Product Page
Provide product photos showing blister packs with a clear label area for DIN, strength, and manufacturer, and ensure accessible alt text including French bilingual prompts for Quebec shoppers where relevant.
For UX, use collapsible sections for Side Effects, Interactions, and When To Seek Care, and include printable SVG counselling leaflets for pharmacists to hand out.
Buying & Storage Advice
In-Store Vs. Online Canadian Purchase Tips
Verify the DIN and expiry date when buying in-store or ordering online, and ask for pharmacist counselling when switching brands or generics.
Confirm provincial coverage and prior-authorisation needs before ordering to avoid unexpected costs.
Note: in our online pharmacy, calan sr is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Caution against cross-border purchases that lack a valid Canadian DIN or pharmacist oversight; if comparing U.S. prices, confirm formulation equivalence (ER vs IR).
Proper Storage With Canadian Climate Considerations
Store verapamil at room temperature 15–30°C away from moisture and heat; avoid freezing during winter shipping and protect from high summer temperatures during transit.
Keep medications out of reach of children and dispose of expired products at community take-back locations.
Online Shipping Checklist:
- Insulated packaging during winter to prevent freeze–thaw cycles.
- Discrete labelling for privacy.
- Confirm courier delivery windows to avoid outdoor exposure to extreme temperatures.
Guidelines For Proper Use
Canadian Doctor/Pharmacist Advice Style
Counselling should be concise, non-alarmist, and evidence-based: name the medicine (verapamil), state the intended benefit, list the dosing plan, and highlight common side effects like constipation and dizziness.
Remind patients not to crush ER tablets and to report symptoms of slow pulse or fainting immediately.
Follow-Up And Monitoring Expectations
Baseline checks: measure blood pressure and resting heart rate before starting therapy, and review the full medication list for interactions, especially beta-blockers and other negative chronotropes.
Monitoring schedule: clinical review within 1–2 weeks of initiation or dose change, periodic liver function assessment if clinically indicated, and medication reconciliation at each refill.
Deprescribing or switching should be gradual with cardiology input for arrhythmia indications and a clear follow-up plan documented on the patient record.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Victoria | British Columbia | 5-7 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
| London | Ontario | 5-9 days |
| Thunder Bay | Ontario | 5-9 days |